Gu Kang-Mo, Min Jinsoo
Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Republic of Korea.
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):566-574. doi: 10.4046/trd.2025.0020. Epub 2025 May 19.
Tuberculosis (TB) care quality assessment has been implemented in the Republic of Korea since 2018. This paper evaluates the results of six rounds of the quality assessment from 2018 to 2023, focusing on the sixth quality assessment in 2023.
This study used cross-linked databases from the Health Insurance Review and Assessment Service, the Korea Disease Control and Prevention Agency, and the Ministry of the Interior and Safety. The study population included newly diagnosed TB patients reported between January and June each year from 2016 to 2023. The sixth quality assessment employed five indicators, which included the treatment success rate. Trends were analyzed using linear regression, and statistical comparisons were performed using chi-square tests.
The sixth quality assessment demonstrated statistically significant improvements across all indicators. Since the fifth assessment, over 95% of patients diagnosed with respiratory TB have undergone TB confirmation tests. Both phenotype and molecular drug susceptibility test coverages showed significant upward trends since the third and fourth assessments, respectively. The treatment success rate, introduced for the first time in the sixth assessment, was reported at 78.3%. Non-TB-related deaths (10.3%) were the most common outcome, other than treatment success.
The TB care quality assessment has contributed to standardizing TB care in Korea and improving management indicators. Further efforts are needed to enhance treatment success through refining the evaluation criteria and implementing innovative management strategies.
自2018年起，韩国开始实施结核病（TB）护理质量评估。本文评估了2018年至2023年六轮质量评估的结果，重点关注2023年的第六次质量评估。
本研究使用了来自健康保险审查和评估服务局、韩国疾病控制和预防机构以及内政和安全部的交联数据库。研究人群包括2016年至2023年每年1月至6月报告的新诊断结核病患者。第六次质量评估采用了五个指标，其中包括治疗成功率。使用线性回归分析趋势，并使用卡方检验进行统计比较。
第六次质量评估显示所有指标均有统计学意义的改善。自第五次评估以来，超过95%的呼吸道结核病确诊患者接受了结核病确诊检查。自第三次和第四次评估以来，表型和分子药敏试验覆盖率均呈现显著上升趋势。第六次评估首次引入的治疗成功率报告为78.3%。除治疗成功外，非结核病相关死亡（10.3%）是最常见的结果。
结核病护理质量评估有助于韩国结核病护理的标准化和管理指标的改善。需要进一步努力，通过完善评估标准和实施创新管理策略来提高治疗成功率。
